Clifford Howell, MD
Vascular Surgery · Oklahoma City, OKNPI 1295700458
Payments from drug & device makers
What this record shows
This record is dominated by education: $10,500 of the $16,917 with a category attached, or 62.1%. Intuitive Surgical accounts for 78.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2019 at $10,545 and has fallen 98.7% since, to $133 in 2025.
Across 75 payments — averaging $225.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- Atricure, Inc.$2K
- Edwards Lifesciences$373
- Johnson & Johnson$308
- Abbott$179
- Zimmer Biomet$119
- plus $475 from 16 others
What the payments were for
- Travel & lodging$3,46620%
- Food & beverage$2,95117%
- Education$10,50062%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 22 | $13,274 |
| Atricure, Inc. | 13 | $2,189 |
| Edwards Lifesciences | 8 | $373 |
| Johnson & Johnson(2 entities) | 7 | $308 |
| Abbott | 2 | $179 |
| Zimmer Biomet | 2 | $119 |
| Endologix LLC | 1 | $87 |
| Angiodynamics, Inc. | 3 | $71 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $50 |
| Getinge USA Sales, LLC | 1 | $38 |
| Abiomed | 1 | $32 |
| Livanova USA, Inc. | 1 | $30 |
| Merck | 2 | $27 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Kls-martin L.p. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| GE HealthCare | 1 | $14 |
| Veran Medical Technologies, Inc. | 1 | $14 |
| Medtronic | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,917 in reported general payments places this provider in the 75th percentile of 35 vascular surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $367 |
| ClopidogrelClopidogrel Bisulfate | 32 | $268 |
| Famotidine | 20 | $200 |
| Potassium Chloride | 16 | $162 |
| Chlorhexidine Gluconate | 38 | $123 |
| Amiodarone Hcl | 13 | $108 |
| Warfarin Sodium | 22 | $96 |
| Oxycodone Hcl | 16 | $79 |
| Metoprolol Tartrate | 26 | $44 |
| Furosemide | 14 | $39 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Oklahoma City
- Jim MeltonOklahoma City$131K
- Lenny StubbsOklahoma City$56K
- Ali AminOklahoma City$41K
- Bernardino RochaOklahoma City$34K
- Sherisa WarrenOklahoma City$15K
- Jones ThomasOklahoma City$14K
- Trenton KinnearOklahoma City$10K
- Donald SpadoneOklahoma City$9K
- James NeelOklahoma City$7K
- Whitney ThorneOklahoma City$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.